Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID02099734

Germ Cell Tumor and Testicular Tumor DNA Registry

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-02-04

1000

Participants Needed

8

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are creating a registry to better understand germ cell tumors (GCT) and other testicular tumors. This registry includes people diagnosed with these tumors, their relatives, and unrelated individuals without these tumors. The study aims to learn more about how these tumors develop, how to prevent and diagnose them, and the outcomes of different treatments. By including family members and unrelated healthy people, the study hopes to uncover why some people develop these tumors while others do not. Participants are grouped into three categories: those with testicular GCTs or non-GCT testicular tumors (including some female GCT cases), relatives of patients with these tumors, and healthy controls who have no personal or family history of these tumors. Participants provide information through questionnaires and give a blood or saliva sample for DNA analysis. If a DNA sample was already given in another approved study, additional sampling may not be needed. During the study, participants will complete questionnaires and provide biological samples to assist in DNA extraction and analysis. Researchers will collect and store this information to build a comprehensive registry over five years. This registry will help track tumor characteristics, family history, and genetic factors. The study is observational, so participants will not receive treatment as part of the trial but will contribute to knowledge about these tumors. The study is open to adults 18 years and older and includes healthy volunteers as well as affected individuals and their relatives.

CONDITIONS

Brief Title

Germ Cell Tumor and Testicular Tumor DNA Registry

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Must be 18 years of age or older
  • Must be able to speak and understand English
  • For case cohort: Must have a diagnosis or suspicion of germ cell tumor and/or a testicular mass
  • For family member cohort: Must be a blood relative of a person with germ cell tumor or testicular tumor
  • For control cohort: Must not have a personal history of cancer except non-melanoma skin cancer
  • For control cohort: Must not have a family history of germ cell tumor or testicular tumor
  • For control cohort: Must not be a blood relative of controls enrolled in this study
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Sample Collection

Duration - Single timepoint

Participants provide a blood or saliva sample for DNA extraction. Some participants may not need to provide an additional sample if they have already contributed one to another approved study.

1 visit (in-person)

Questionnaires

Duration - Single timepoint

Participants complete behavioral questionnaires related to the study.

1 visit (in-person) or remote completion

Long-term Monitoring

Duration - Up to 5 years

Participants contribute data to the Germ Cell Tumor and Testicular Tumor DNA Registry over time.

Periodic contact for data updates

Trial Site Locations

Total: 8 locations

1

Memorial Sloan Kettering Basking Ridge

Basking Ridge, New Jersey, United States

Actively Recruiting

2

Memorial Sloan Kettering Monmouth

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Cold Springs Harbor Laboratory (Specimen Analysis)

Cold Spring Harbor, New York, United States, 11724

Not Yet Recruiting

5

Memorial Sloan Kettering Commack

Commack, New York, United States, 11725

Actively Recruiting

6

Memorial Sloan Kettering Westchester

Harrison, New York, United States, 10604

Actively Recruiting

7

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

Actively Recruiting

8

Memorial Sloan Kettering Nassau

Uniondale, New York, United States, 11553

Not Yet Recruiting

Loading map...

Research Team

D

Darren Feldman, MD

J

Joel Sheinfeld, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

A Single-Arm Phase II Trial of Aspirin to Prevent Venous Thr...

Germ Cell Tumor

Actively Recruiting

3 locations

A First-In-Human Study of ZW251, a Glypican-3 Targeting Anti...

Hepatocellular Carcinoma

Actively Recruiting

25 locations

Phase 3 Accelerated Versus Standard BEP Chemotherapy for Int...

Germ Cell Tumor

Actively Recruiting

28 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here